IHE
iShares US Pharmaceuticals ETF
NAV as of
4 Week: 169.60 - 178.87
52 Week: 166.62 - 191.47
Latest Closing Price
178.87
Premium / Discount
0.04
Expense Ratio
0.4%
Investment Objective
The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -4.07 | 0.89 | -4.59 |
| 1 Day | -0.17 | 0.00 | 0.00 |
| 1 Week | 2.63 | 1.13 | 2.34 |
| 1 Month | 3.71 | 4.34 | 0.86 |
| 3 Months | -5.29 | 7.70 | -0.69 |
| 6 Months | 1.44 | 10.20 | 0.14 |
| 1 Year | -5.03 | 14.13 | -0.36 |
| 2 Years | -4.45 | 22.89 | -0.19 |
| 3 Years | 1.98 | 26.11 | 0.08 |
| 5 Years | 13.84 | 42.45 | 0.33 |
| 10 Years | 53.65 | 59.97 | 0.89 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 40.5219 | 29.7469 | 8.8160 | -11.7217 | 10.6598 | -7.6721 | 15.4901 | 13.8182 | 12.8271 | -4.7768 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 87.0000 | 31.0000 | 35.0000 | 59.0000 | 100.0000 | 79.0000 | 97.0000 | 80.0000 | 39.0000 | 24.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 20/12/2016 | 27/12/2016 | 0.3377 |
| 20/06/2016 | 26/06/2016 | 0.3336 |
| 23/12/2014 | 30/12/2014 | 0.3856 |
| 23/09/2014 | 29/09/2014 | 0.3937 |
| 23/06/2014 | 29/06/2014 | 0.7593 |
| 24/03/2014 | 30/03/2014 | 0.2794 |
| 26/12/2013 | 02/01/2014 | 0.0628 |
| 22/12/2013 | 29/12/2013 | 0.2748 |
| 23/09/2013 | 29/09/2013 | 0.2897 |
| 25/06/2013 | 01/07/2013 | 0.3263 |
Portfolio Data
Total Number of Holdings: 38
Number of Bond Holdings: 0
Number of Equity Holdings: 34
Total Market Value: 567,449,139
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Eli Lilly and Co | 25.8243 | 247,730 | 0 | 146,539,727 |
| 2 | Johnson & Johnson | 23.4044 | 877,895 | 0 | 132,807,956 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 53.89 |
| Large | 12.98 |
| Medium | 12.31 |
| Small | 15.38 |
| Micro | 4.92 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
11.7607
Price/Book*
2.6390
Price/Sales*
2.7407
Price/Cash Flow*
10.5178
Dividend Yield*
2.3325
Growth Measures
Long-Term Earnings
7.7728
Historical Earnings
11.7943
Sales Growth
1.2505
Cash-Flow Growth
-4.7933
Book-Value Growth
1.6300
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
